Aller au contenu principal
Fermer

Transgene to Participate in Upcoming Investor Meetings
information fournie par Boursorama CP 07/04/2026 à 17:45

Strasbourg, France, April 7, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of:

- Investor Access Event (by Allinvest Securities), on April 9, 2026, in Paris (France);
- Life Sciences Conference (by Van Lanschot Kempen), on April 16, 2026, in Amsterdam (Netherlands).

Next financial communications:
- April 29, 2026: First Quarter 2026 Financial Results
- May 22, 2026: Annual Shareholders’ Meeting


.../...

Valeurs associées

0,7400 EUR Euronext Paris -0,54%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

valeur

dernier

var.

84,62 -0,52%
8 382,43 +0,19%
Or
4 035,86 -0,57%
1,14675 0,00%
70,64 -0,79%
Chargement...